Retour
Fourchette du Jour
34,39 €
34,39 €
Fourchette 52 Semaines
6,98 €
34,39 €
Volume
21 644
Moyenne 50J / 200J
13,01 €
/
8,48 €
Clôture Précédente
34,39 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -67,0 | 0,2 |
| P/B | — | 3,0 |
| ROE % | — | 3,5 |
| Net Margin % | -72,2 | 3,8 |
| Rev Growth 5Y % | 32,9 | 9,7 |
| D/E | — | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
1,99 €
1,33 € – 2,45 €
|
145,93M | 1 |
| FY2029 |
3,10 €
2,08 € – 3,82 €
|
152,21M | 1 |
| FY2028 |
1,42 €
0,95 € – 1,74 €
|
93,69M | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2025-12-09 | -0,31 € | -0,57 € | -85,7% |
| 2025-06-17 | -0,45 € | -0,13 € | +70,7% |
| 2024-12-03 | N/A | -0,55 € | — |
| 2024-06-25 | N/A | -0,63 € | — |
| 2023-12-21 | N/A | -0,31 € | — |
| 2023-03-31 | N/A | -0,79 € | — |
| 2022-09-30 | N/A | -0,53 € | — |
| 2022-03-31 | N/A | -0,58 € | — |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Revenue grew 32,91% annually over 5 years — strong growth
Generating 17,81M in free cash flow
PEG of 0,36 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 145,92%
Capital efficient — spends only 6,50% of revenue on capex
Croissance
Revenue Growth (5Y)
32,91%
Revenue (1Y)178,83%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
N/A
ROIC-19,18%
Net Margin-72,19%
Op. Margin-42,44%
Sécurité
Debt / Equity
N/A
Current Ratio2,70
Interest Coverage-2,13
Valorisation
P/E Ratio
-66,97
Forward P/EN/A
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 178,83% | Revenue Growth (3Y) | 60,26% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 32,91% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 25,54M | Net Income (TTM) | -18,44M |
| ROE | N/A | ROA | -20,38% |
| Gross Margin | 100,00% | Operating Margin | -42,44% |
| Net Margin | -72,19% | Free Cash Flow (TTM) | 17,81M |
| ROIC | -19,18% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2,70 |
| Interest Coverage | -2,13 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -66,97 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | 48,34 |
| PEG Ratio | 0,36 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 38,39 | Fwd Earnings Yield | N/A |
| FCF Yield | 1,44% | ||
| Market Cap | 1,23B | Enterprise Value | 1,23B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 25,54M | 9,16M | 9,94M | 4,09M | 8,19M |
| Net Income | -18,44M | -25,04M | -32,01M | -24,81M | -19,02M |
| EPS (Diluted) | -0,63 | -0,88 | -1,27 | -1,00 | -0,86 |
| Gross Profit | 25,54M | 9,16M | 9,94M | 4,09M | 6,74M |
| Operating Income | -10,84M | -20,98M | -24,03M | -23,81M | -15,61M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 90,45M | 36,95M | 29,34M | 44,30M | 63,61M |
| Total Liabilities | 106,82M | 77,77M | 71,63M | 57,67M | 54,69M |
| Shareholders' Equity | -16,37M | -40,82M | -42,29M | -13,37M | 8,92M |
| Total Debt | 58,76M | 58,96M | 57,71M | 47,49M | 43,35M |
| Cash & Equivalents | 59,04M | 19,46M | 6,47M | 24,62M | 47,10M |
| Current Assets | 80,62M | 27,26M | 19,57M | 34,07M | 56,33M |
| Current Liabilities | 29,87M | 16,47M | 57,03M | 38,24M | 13,60M |